Celularity, Inc. (CELU)
0.8301
+0.02
(+2.24%)
USD |
NASDAQ |
Jun 09, 12:46
Celularity SG&A Expense (Quarterly) : 15.06M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 5.034M |
| Exicure, Inc. | 1.291M |
| Century Therapeutics, Inc. | 6.579M |
| Absci Corp. | 9.058M |
| Cardio Diagnostics Holdings, Inc. | 1.652M |